Less Ads, More Data, More Tools Register for FREE

Pin to quick picksRIT Capital Partners Regulatory News (RCP)

Share Price Information for RIT Capital Partners (RCP)

Share Price is delayed by 15 minutes
Get Live Data
2,320.00    5.00 (0.22%)
Bid:
2,295.00
Ask:
2,310.00
Spread: 15.00 (0.654%)
Market Cap: £3.14b
RCP Live PriceLast checked at - London Stock Exchange

Intraday RIT Capital Partners Share Chart

Net Asset Value(s)

17 Jun 2024 07:00

RNS Number : 5730S
RIT Capital Partners PLC
17 June 2024
 

RIT Capital Partners plc (LEI: P31Q1NLTW35JJGHA4667)

 

17 June 2024

 

31 May 2024 Net Asset Value

 

RIT Capital Partners plc announces that its unaudited diluted Net Asset Value ("NAV") as at 31 May 2024, calculated with debt at fair value, was 2,540p per £1 ordinary share (30 April 2024: 2,511p).

 

May 2024 Commentary

 

Global equities rebounded in May with US Federal Reserve continuing to signal interest rate cuts and economic data that supported the disinflation narrative, resulting in the S&P 500 rising by +5%. European shares also showed recovery, with STOXX 600 returning +3.5% reflecting the market's anticipation of a rate cut by the ECB. On the other hand, despite relatively robust economic data, China saw a -0.5% decline across the Shenzhen 300 as ongoing real estate debt pressures continue to weigh on investor sentiment. The US dollar gave back some of its year-to-date strength and fell -2% against sterling in the month. The price of gold continued to rise, reaching an all-time high of $2,450 in the same period.

 

Portfolio highlights

 

Our portfolio posted positive performance in May, with a total return of 1.1% despite a partial offsetting of returns caused by our exposure to the US dollar. This increase in value was driven by gains across all three of our strategic investment pillars.

 

·

An increase in the value of our Quoted Equities book was driven by healthy returns from our external managers and strong performance from our directly held small and mid-cap equities, an area where we currently see opportunity. With some expected offset on our portfolio hedges, the book saw a positive outcome overall. 

 

·

Private Investments were a solid contributor during the month, driven by gains from our private funds which saw an uplift in Q1 valuations. As of 31 May, 97% of our private funds were held at 31 March reported valuations and 2% were held at 31 December valuations. All private direct holdings are valued at 31 December, in line with our half-yearly valuation process for these holdings.

 

·

Uncorrelated Strategies also contributed positively to our total return for the month, driven largely by credit holdings performing strongly.

 

·

The Board continued its active buyback programme, generating a further accretive impact to the NAV per share. For the year to 31 May, the Company has repurchased approximately 1.5 million shares on behalf of shareholders.

 

 

 

For more information:

J. Rothschild Capital Management (Manager):

T: 020 7647 8565

E: investorrelations@ritcap.co.uk

 

Numis (Joint Broker):

David Benda

T: 020 7260 1000

 

JP Morgan Cazenove (Joint Broker):

William Simmonds

T: 020 3493 8000

 

Brunswick Group LLP (Media enquiries):

Nick Cosgrove, Sofie Brewis

T: 020 7404 5959

E: RIT@BrunswickGroup.com 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
NAVEZLFFZQLZBBK
Date   Source Headline
16th Sep 20197:00 amRNSNet Asset Value(s)
14th Aug 20197:00 amRNSNet Asset Value(s)
5th Aug 20197:00 amRNSHalf-year Report
17th Jul 20197:00 amRNSNet Asset Value(s)
3rd Jul 20192:42 pmRNSQuarterly Disclosure: Listing Rule 15.6.8
18th Jun 20195:04 pmRNSDirector/PDMR Shareholding
17th Jun 20194:20 pmRNSHolding(s) in Company
14th Jun 20197:00 amRNSNet Asset Value(s)
15th May 20197:00 amRNSNet Asset Value(s)
12th Apr 20197:00 amRNSNet Asset Value(s)
3rd Apr 20193:59 pmRNSQUARTERLY DISCLOSURE - Listing Rule 15.6.8
22nd Mar 20194:01 pmRNSDirector/PDMR Shareholding
14th Mar 20197:00 amRNSNet Asset Value(s)
5th Mar 20197:00 amRNSAnnual Financial Report
18th Feb 20197:00 amRNSNet Asset Value(s)
5th Feb 20197:00 amRNSNet Asset Value(s)
8th Jan 201910:02 amRNSQuarterly Disclosure: Listing Rule 15.6.8
14th Dec 20187:00 amRNSNet Asset Value(s)
30th Nov 201810:53 amRNSComposition of Board Committee
14th Nov 20187:00 amRNSNet Asset Value(s)
29th Oct 20184:59 pmRNSComposition of Board Committee
16th Oct 201811:11 amRNSDirector Declaration
12th Oct 20187:00 amRNSNet Asset Value(s)
5th Oct 20185:03 pmRNSDirector/PDMR Shareholding
4th Oct 20185:46 pmRNSQuarterly Disclosure: Listing Rule 15.6.8
14th Sep 20187:00 amRNSNet Asset Value(s)
24th Aug 20183:15 pmRNSAppointment of Joint Broker
14th Aug 20187:00 amRNSNet Asset Value(s)
7th Aug 20187:00 amRNSHalf-year Report
18th Jul 20187:00 amRNSNet Asset Value(s)
3rd Jul 20186:00 pmRNSQuarterly Disclosure: Listing Rule 15.6.8
14th Jun 20187:00 amRNSNet Asset Value(s)
15th May 20187:00 amRNSNet Asset Value(s)
26th Apr 201812:41 pmRNSDirectorate Change
26th Apr 201812:27 pmRNSResult of AGM
16th Apr 20187:25 amRNSNet Asset Value(s)
6th Apr 20185:54 pmRNSQuarterly Disclosure: Listing Rule 15.6.8
28th Mar 20185:09 pmRNSDirector/PDMR Shareholding
26th Mar 201811:54 amRNSDirectorate Change
14th Mar 20187:00 amRNSNet Asset Value(s)
5th Mar 20186:00 pmRNSDirector/PDMR Shareholding
27th Feb 20187:00 amRNSFinal Results and Dividend
14th Feb 20187:00 amRNSNet Asset Value(s)
5th Feb 201810:02 amRNSInitiation research from QuotedData
31st Jan 20187:00 amRNSNet Asset Value(s)
22nd Dec 201710:08 amRNSDirector/PDMR Shareholding
22nd Dec 20177:00 amRNSDirectorate Change
20th Dec 20174:17 pmRNSDirector Declaration
14th Dec 20177:00 amRNSNet Asset Value(s)
27th Nov 20175:54 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.